Problem statement: Answer the multiple-choice question.
Query: Which drug has a 13.750% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCC(Oc1ccc(C)cc1)C(=O)Nc1ccccc1C(=O)N1CCOCC1
(b) Cc1cc(C(=O)Nc2ccccc2N2CCOCC2)ccc1[N+](=O)[O-]
Answer: a. CCC(Oc1ccc(C)cc1)C(=O)Nc1ccccc1C(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(Oc1ccc(C)cc1)C(=O)Nc1ccccc1C(=O)N1CCOCC1
CCC(Oc1ccc(C)cc1)C(=O)Nc1ccccc1C(=O)N1CCOCC1
2-(4-methylphenoxy)-N-[2-(morpholine-4-carbonyl)phenyl]butanamide